194 related articles for article (PubMed ID: 35969769)
1. Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease.
Shi H; Shao B; Gao L; Venkatesan T; McDaniel JM; Zhou M; McGee S; Yu P; Ahamed J; Journeycake J; George JN; Xia L
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207592119. PubMed ID: 35969769
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
[TBL] [Abstract][Full Text] [Related]
3. Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice.
Shi H; Gao L; Kirby N; Shao B; Shan X; Kudo M; Silasi R; McDaniel JM; Zhou M; McGee S; Jing W; Lupu F; Cleuren A; George JN; Xia L
Blood; 2024 Mar; 143(13):1293-1309. PubMed ID: 38142410
[TBL] [Abstract][Full Text] [Related]
4. Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
Rossato P; Glantschnig H; Canneva F; Schuster M; Coulibaly S; Schrenk G; Voelkel D; Dockal M; Plaimauer B; Rottensteiner H; Gritsch H; Federti E; Matte A; De Franceschi L; Scheiflinger F; Hoellriegl W
J Thromb Haemost; 2023 Feb; 21(2):269-275. PubMed ID: 36700507
[TBL] [Abstract][Full Text] [Related]
5. Contribution of ADAMTS13-independent VWF regulation in sickle cell disease.
Hunt RC; Katneni U; Yalamanoglu A; Indig FE; Ibla JC; Kimchi-Sarfaty C
J Thromb Haemost; 2022 Sep; 20(9):2098-2108. PubMed ID: 35753044
[TBL] [Abstract][Full Text] [Related]
6. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
8. Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
Rossato P; Federti E; Matte A; Glantschnig H; Canneva F; Schuster M; Coulibaly S; Schrenk G; Voelkel D; Dockal M; Plaimauer B; Andolfo I; Iolascon A; Rottensteiner H; Gritsch H; Scheiflinger F; Hoellriegl W; Franceschi L
Haematologica; 2022 Nov; 107(11):2650-2660. PubMed ID: 35443560
[TBL] [Abstract][Full Text] [Related]
9. VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion.
Fogarty H; Ahmad A; Atiq F; Doherty D; Ward S; Karampini E; Rehill A; Leon G; Byrne C; Geoghegan R; Conroy H; Byrne M; Budde U; Schneppenheim S; Sheehan C; Ngwenya N; Baker RI; Preston RJS; Tuohy E; McMahon C; O'Donnell JS
Blood Adv; 2023 Nov; 7(22):6974-6989. PubMed ID: 37773926
[TBL] [Abstract][Full Text] [Related]
10. Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
Chenou F; Hounkpe BW; Domingos IF; Tonassé WV; Batista THC; Santana RM; Arcanjo GDS; Alagbe AE; Araújo ADS; Lucena-Araújo AR; Bezerra MAC; Costa FF; Sonati MF; De Paula EV; Dos Santos MNN
Ann Hematol; 2021 Nov; 100(11):2669-2676. PubMed ID: 34453189
[TBL] [Abstract][Full Text] [Related]
11. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.
Chen J; Hobbs WE; Le J; Lenting PJ; de Groot PG; López JA
Blood; 2011 Mar; 117(13):3680-3. PubMed ID: 21300978
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS13 activity in sickle cell disease.
Schnog JJ; Kremer Hovinga JA; Krieg S; Akin S; Lämmle B; Brandjes DP; Mac Gillavry MR; Muskiet FD; Duits AJ;
Am J Hematol; 2006 Jul; 81(7):492-8. PubMed ID: 16755558
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.
Demagny J; Driss A; Stepanian A; Anguel N; Affo L; Roux D; Habibi A; Benghezal S; Capdenat S; Coppo P; Driss F; Veyradier A
Res Pract Thromb Haemost; 2021 Jan; 5(1):197-203. PubMed ID: 33537544
[TBL] [Abstract][Full Text] [Related]
14. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.
Zhou Z; Han H; Cruz MA; López JA; Dong JF; Guchhait P
Thromb Haemost; 2009 Jun; 101(6):1070-7. PubMed ID: 19492149
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity.
Al-Awadhi A; Adekile A; Marouf R
Acta Haematol; 2021; 144(2):182-189. PubMed ID: 32987383
[TBL] [Abstract][Full Text] [Related]
16. Molecular link between intravascular hemolysis and vascular occlusion in sickle cell disease.
Zhou Z; Yee DL; Guchhait P
Curr Vasc Pharmacol; 2012 Nov; 10(6):756-61. PubMed ID: 22272904
[TBL] [Abstract][Full Text] [Related]
17. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
[TBL] [Abstract][Full Text] [Related]
18. Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease.
van der Land V; Peters M; Biemond BJ; Heijboer H; Harteveld CL; Fijnvandraat K
Thromb Res; 2013; 132(6):712-7. PubMed ID: 24182550
[TBL] [Abstract][Full Text] [Related]
19. The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease.
Beckman JD; Sparkenbaugh EM
Curr Opin Hematol; 2023 Sep; 30(5):153-158. PubMed ID: 37462409
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
Al-Awadhi A; Adekile A; Marouf R
J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
